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Abstract
Eosinophilic fasciitis is a rare condition. It is generally limited to the distal parts
of the arms and legs. MRI is the ideal imaging modality for diagnosing and
monitoring this condition. MRI findings typically evidence only fascial involvement
but on a less regular basis signal abnormalities may be observed in neighboring
muscle tissue and hypodermic fat. Differential diagnosis of eosinophilic fasciitis
by MRI requires the exclusion of several other superficial and deep soft tissue
disorders.
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Abstract  Eosinophilic  fasciitis  is  a  rare  condition.  It  is  generally  limited  to  the  distal  parts  of
the arms  and  legs.  MRI  is  the  ideal  imaging  modality  for  diagnosing  and  monitoring  this  condi-
tion. MRI  ﬁndings  typically  evidence  only  fascial  involvement  but  on  a  less  regular  basis  signal
abnormalities  may  be  observed  in  neighboring  muscle  tissue  and  hypodermic  fat.  Differential
diagnosis of  eosinophilic  fasciitis  by  MRI  requires  the  exclusion  of  several  other  superﬁcial  and
deep soft  tissue  disorders.
© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Eosinophilic  fasciitis  is  a  rare  condition  that  was  ﬁrst  described  by  Shulman  in  1974  [1].
Magnetic  resonance  imaging  (MRI)  is  the  ideal  imaging  modality  both  for  diagnosing  and
monitoring  this  condition.  MRI  examination  typically  evidences  only  fascial  involvement  but
on  a  less  regular  basis  signal  abnormalities  may  be  observed  in  neighboring  muscle  tissue
and  hypodermic  fat.  Such  abnormalities  further  complicate  the  differential  diagnosis  of
eosinophilic  fasciitis  over  other  candidate  superﬁcial  and  deep  soft  tissue  conditions  such
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as  scleroderma,  necrotizing  fasciitis  or  myositis.  Following
an  overview  of  fasciae  anatomy,  we  will  describe  the  clin-
ical  and  biological  speciﬁcs  of  eosinophilic  fasciitis  before
detailing  its  typical  MRI  features,  variants  and  differential
diagnosis.
Fasciae anatomy and physiology
In  the  limbs,  fasciae  consist  of  a  continuous  sheet  or  band  of
ﬁbrous  tissue  that  entirely  covers  a  group  of  muscles  to  form
a  muscle  compartment  [2].  Superﬁcial  fasciae  are  underlying
to  the  dermis.  Fat  may  accumulate  in  this  region  and  form  a
hypodermic  layer  of  adipose  tissue  of  varying  thickness  that
contains  nerves  and  vessels.  Deep  fascia,  a  more  compact
layer  than  superﬁcial  fascia  formed  by  a  dense  array  of  col-
lagen  ﬁbers,  often  cannot  be  distinguished  from  the  muscle
aponeurosis.  Intermuscular  septa  extend  from  the  deep  fas-
cia  and  separate  various  muscle  groups  into  compartments.
Although  commonly  used,  the  terms  ‘‘superﬁcial  fascia’’
and  ‘‘deep  fascia’’  are  considered  as  incorrect  by  the  FICAT
(Federative  International  Committee  on  Anatomical  Termi-
nology)  due  to  the  lack  of  international  consensus  on  the
histological  terms  used  to  refer  to  the  different  layers  of
connective  tissue  [3].  In  addition,  these  terms  do  not  always
refer  to  the  same  structure  when  used  by  an  anatomical
pathologist,  a  surgeon  or  a  radiologist.
To  maintain  consistency  and  avoid  any  confusion,  it  is
recommended  to  use  the  international  terminology  that
distinguishes  cutaneous  (superﬁcial)  fascia  for  the  hypoder-
mic  vascular  connective  tissue,  deep  peripheral  fascia  for
the  fascia  surrounding  whole  muscle  groups  and  deep  inter-
muscular  fascia  for  intermuscular  septa  and  aponeuroses
[2—4].
Eosinophilic fasciitis (Shulman’s syndrome)
Eosinophilic  fasciitis,  also  known  as  Shulman’s  syndrome,
is  characterized  by  sclerotic  skin  lesions  associated  with
an  increased  sedimentation  rate,  hypergammaglobuline-
mia  and  eosinophilia  [1,5].  Since  the  ﬁrst  description,  no
international  consensus  has  been  reached  regarding  ofﬁcial
diagnostic  criteria  for  this  condition  [6].
Eosinophilic  fasciitis  is  a  rare  disease,  the  exact  incidence
of  which  is  still  unknown.  Since  Shulman’s  ﬁrst  description,
over  300  cases  have  been  reported  in  the  literature  [6].  The
average  age  of  onset  is  approximately  40—50  years  [7,8].
Depending  on  the  studies,  gender  prevalence  differences
tend  to  vary,  suggesting  that  the  disorder  is  not  sex-related
[7—9].  Strenuous  physical  effort  or  trauma  preceding  the
onset  of  symptoms  is  often  among  the  main  causal  fac-
tors  reported  [7,8,10].  Some  cases  have  been  reported  to
occur  after  taking  medication  (statins,  phenytoin,  ramipril,
subcutaneous  heparin)  or  bacterial  infection  (borreliosis,
mycoplasma)  [6].  In  one  case  the  condition  was  found  to
be  associated  with  lupus  [11].
At  least  10%  of  patients  with  eosinophilic  fasciitis
show  some  kind  of  blood  disorder:  thrombocytopenia,
myelomonocytic  leukemia,  chronic  lymphocytic  leukemia
and  other  myeloproliferative  disorders  [6].  However,  it  is
still  not  clear  whether  these  blood  disorders  cause  the
fasciitis  (paraneoplastic  syndrome)  or  if,  on  the  contrary,
fasciitis  triggers  the  blood  disorder.
The  pathophysiology  of  eosinophilic  fasciitis  is  still
unknown.  Some  authors  have  suggested  that  eosinophilia
and  tissue  lesions  could  be  caused  by  circulating  T-cell  clones
and  increased  interleukin-5  production  [12]. This  hypothesis
is  supported  by  the  fact  that  the  contents  of  the  vacuoles  of
polymorphonuclear  leukocytes  and  related  neurotoxins  are
involved  in  fascia  ﬁbrosis  [6]. Other  authors  have  suggested
that  mast  cells  and  cytokines  cause  eosinophilia  which  is
observed  in  eosinophilic  fasciitis  patients  [13].
Clinical  manifestations  serve  as  a  guide  for  diagnosis.  Up
to  90%  of  patients  present  with  cutaneous  manifestations,
which  include  edema,  skin  induration  or  so-called  orange
peel  or  cobblestone  skin  with  hyperpigmentation  [7].  The
condition  usually  comprises  two  phases:  the  early  phase,
characterized  by  non-speciﬁc  symptoms  such  as  edema  of
the  limbs  that  becomes  tender  and  sometimes  painful,  grad-
ually  gives  way  to  the  established  stage  during  the  course
of  which  edema  disappears  and  is  replaced  by  painless  skin
induration.  Venous  furrowing  along  the  veins  within  the  inﬁl-
trated  area,  also  called  the  ‘‘groove  sign’’,  is  observed  in
nearly  half  of  the  patients  and  is  highly  evocative  of  fasci-
itis  or  deep  ﬁbrosis  [6]. The  condition  predominately  affects
the  distal  parts  of  the  limbs  and  more  rarely  the  front  of  the
neck  and  trunk.  It  is  generally  symmetric  and  patients  are
more  likely  to  have  symptoms  on  the  arms  (88%)  than  on
the  legs  (70%)  [10,14]. The  head  is  generally  not  affected,
and  the  hands  and  feet  are  rarely  involved  [15,16].  Typically
Raynaud’s  phenomenon  is  not  present  and  normal  ﬁndings
are  observed  with  capillaroscopy  [6].  Skin  manifestations
are  often  associated  with  myalgia  (67—86%  of  patients)  and
joint  contractures  or  inﬂammatory  arthralgia  (up  to  40%  of
patients)  [10,14].
Eosinophilia  is  observed  in  63  to  93%  of  patients  and,
although  important  in  nature,  tends  to  decrease  or  even
disappear  as  the  condition  becomes  established.  Therefore,
although  highly  evocative,  eosinophilia  is  not  indispensable
for  diagnosis  [10,14,17]. No  relationship  has  been  found
between  the  degree  of  eosinophilia  and  the  severity  of  the
disease  [7,8,17].
An  inﬂammatory  syndrome  is  common  with  increased
C-reactive  protein  levels  (55%),  a  greater  erythrocyte
sedimentation  rate  (up  to  63%)  and  generally  polyclonal
hypergammaglobulinemia  (more  than  50%  of  patients)  [6].
Autoimmune  screening  for  ANCA  and  anti-DNA/ENA  anti-
bodies  is  negative,  although  anti-nuclear  antibodies  may  be
detected  in  15—20%  of  cases  [6].
In  practice,  diagnosis  is  made  based  on  deep  skin  biopsy
(skin  and  muscle)  of  skin  abnormalities,  which  evidences  a
thickening  of  the  fascia  due  to  lymphocyte  and  plasma  cell
inﬁltration  with  a  varying  percentage  of  eosinophil  granulo-
cytes.  Eosinophils  can  actually  be  absent  in  fascia  biopsies
although  eosinophilia  is  observed  in  blood  samples.  For
this  reason,  it  seems  preferable  to  designate  the  condition
as  ‘‘fasciitis  with  eosinophilia’’  rather  than  ‘‘eosinophilic
fasciitis’’  [18].
In the  same  way  as  for  diagnostic  criteria,  there  is  no
general  consensus  with  regard  to  therapy  and  assessment
of  the  patients’  response  to  treatment.  In  practice,  high
doses  of  corticosteroids  are  given  as  ﬁrst-line  line  treat-
ment  (0.5—1  mg  per  kg  and  per  day).  The  dose  is  gradually
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decreased  over  a  period  of  several  months  to  several  years
depending  on  the  clinical  course  of  the  condition  [6].  Numer-
ous  alternatives  have  been  advanced  in  cases  of  persistent
eosinophilic  fasciitis,  notably  immunosuppressive  drugs  such
as  methotrexate.  When  the  prognosis  is  not  determined  by
the  presence  of  a  blood  disorder,  corticosteroid  therapy  gen-
erally  leads  to  a  favorable  outcome  with  partial  or  complete
remission  in  70—90%  of  cases  [7,10].  In  the  patient  popula-
tion  studied  by  Lebeaux  et  al.,  corticosteroid  therapy  was
continued  on  average  for  45  months  ±  31  months  and  adjunc-
tive  immunosuppressive  therapy  was  required  in  44%  of  cases
and  lasted  on  average  24.7  months  (±  23.3  months)  [10].
Complete  remission  was  observed  in  36%  of  patients  who
received  this  combination  treatment.
Prognosis  factors  associated  with  a  risk  of  poor  response
to  treatment  and  a  greater  risk  of  residual  ﬁbrosis  are
skin  lesions  with  morphea,  onset  of  symptoms  before  age
12,  spread  of  lesions  to  the  trunk  and  dermal  ﬁbroscle-
rosis  evidenced  by  histology  [17].  Poor  prognosis  was  also
associated  with  an  absence  of  high  doses  of  corticosteroid
therapy  as  ﬁrst-line  treatment  and  a  delay  of  more  than
6  months  between  the  onset  of  symptoms  and  diagnosis
[6].
MRI ﬁndings in eosinophilic fasciitis
Typical form
Although  not  strictly  required  for  diagnosis,  MRI  is  carried
out  on  a  regular  basis  as  part  of  the  initial  assessment  of
eosinophilic  fasciitis.  It  is  the  ideal  imaging  modality  both
for  diagnosing  and  monitoring  the  course  of  this  condition
[16].
In  accordance  with  published  data,  the  minimal  acquisi-
tion  protocol  consists  in  T1-weighted  SE  images  and  short  tau
inversion  recovery  (STIR)  images  in  the  axial  plane.  Injection
of  a  gadolinium-based  contrast  agent  is  not  performed  sys-
tematically.  However  when  performed,  it  is  followed  by  a
fat-saturated  T1-weighted  SE  sequence  in  the  axial  plane.
The  condition  is  generally  bilateral  so  both  limbs  should  be
studied  on  a  comparative  basis.
Prior  to  the  injection  of  contrast  agent,  MR  images
typically  show  a  thickening  of  deep  fasciae  (peripheral
deep  fasciae  and  more  rarely  intermuscular  fasciae)  on
T1-weighted  sequences  that  appears  with  a  relatively
higher  signal  intensity  than  that  of  muscle  tissue  on  fat-
suppressed  or  fat-saturated  T2-weighted  sequences  [16].
Following  injection  of  a  gadolinium-based  contrast  agent,
thickened  fasciae  appear  with  markedly  enhanced  sig-
nal  intensity  (Fig.  1).  Abnormalities  are  typically  limited
to  the  fasciae,  sparing  muscles  and  hypodermic  fat.  MRI
also  helps  to  identify  the  most  affected  regions  where
biopsies  should  be  collected  [19].  MRI  is  also  useful  to
follow  the  course  of  the  disease  in  treated  patients.
Although  the  evolution  of  laboratory  abnormalities  fol-
lowing  treatment  was  variable,  Baumann  et  al.  found
that  MRI  ﬁndings  were  closely  correlated  with  the  dis-
ease’s  clinical  evolution  with  complete  disappearance
of  imaging  abnormalities  in  fully  remitted  patients  and
incomplete  regression  in  patients  who  responded  only  par-
tially  to  treatment  (Fig.  2)  [16].  Nevertheless,  no  strict
Figure 1. Typical MRI features of eosinophilic fasciitis in a
37-year-old man. Axial STIR-weighted (a) and T1SE-weighted
sequences before (b) and after (c) injection of gadolinium-based
contrast agent. Symmetric bilateral involvement in the forearms
with thickening and high signal intensity (STIR-weighted sequence)
of the deep fasciae with enhancement (arrows).
criteria  have  been  deﬁned  to  assess  the  response  to
treatment  using  MRI,  the  response  to  treatment  being
simply  referred  to  as  partial  or  complete  depending  on
whether  fascia  abnormalities  persist  following  treatment
[16]. In  the  absence  of  a  prospective  study,  the  optimal
or  recommended  timing  between  starting  treatment  and
MRI  follow-up  has  yet  to  be  determined  for  eosinophilic
fasciitis.  Kissin  et  al.  recently  evaluated  whether  the  thick-
ness  and  compressibility  of  subcutaneous  tissue  measured
by  ultrasound  examination  could  be  of  help  in  diagnos-
ing  eosinophilic  fasciitis.  However,  the  usefulness  of  this
technique  seemed  limited  when  compared  with  magnetic
resonance  [20].
Variants
On  a  less  regular  basis,  abnormalities  of  both  the  fasciae
and  neighboring  tissues  are  observed  on  MRI.  In  some  cases,
the  hyperintense  signal  intensity  on  T2-weighted  images  and
enhancement  have  been  reported  to  extend  to  the  muscle
ﬁbers  and  subcutaneous  fat  adjacent  to  the  affected  fas-
ciae  (Fig.  3) [16,21,22].  In  a  group  of  eight  patients  studied
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Figure 2. Typical MRI features of eosinophilic fasciitis in a 52-
year-old man before and after treatment. a. Axial STIR-weighted
sequence showing bilateral symmetric thickening and high signal
intensity in peripheral deep fasciae (arrows) and intermuscular fas-
ciae (arrowheads), mainly in the posterior muscle compartments of
the thigh. b. Identical sequence performed 12 months later follow-
ing long-term corticosteroid therapy showing clear regression of the
lesions. The latter are barely visible with only very mild focal high
signal intensity in the deep intermuscular fasciae (arrowheads).
by  Baumann  et  al.,  such  abnormalities  were  visible  in  the
muscles  adjacent  to  the  fasciae  in  3  cases  (37.5%)  and  in
subcutaneous  tissue  in  2  cases  (25%)  [16].  In  the  series  by
Moulton  et  al.,  the  abnormalities  extended  to  muscle  ﬁbers
adjacent  to  the  fasciae  in  the  12  cases  assessed  during  the
acute  phase  (less  than  6  months)  and  in  2  out  of  3  cases
assessed  following  implementation  of  corticosteroid  ther-
apy  during  the  subacute  phase  (between  6  and  12  months
after  the  onset  of  symptoms)  [23].  Nonetheless,  such  sig-
nal  abnormalities  in  muscle  or  hypodermic  tissue  remain
of  lesser  importance  and  fasciae  abnormalities  are  still  the
main  MRI  ﬁnding.  In  addition,  these  secondary  abnormalities
are  always  limited  to  neighboring  tissues  and  therefore  prob-
ably  reﬂect  the  extension  of  inﬂammation  to  the  muscles
directly  next  to  the  fascia,  as  can  be  observed  at  histological
analysis  [16,24].  As  for  the  hypodermic  signal  abnormalities
observed  in  the  report  by  Baumann  et  al.,  they  could  be
explained  by  panniculitis-like  sclerotic  and  ﬁbrous  changes
[16].  The  exact  frequency  of  these  atypical  presentations  of
eosinophilic  fasciitis  has  yet  to  be  determined  and  no  rela-
tionship  has  been  reported  up  to  date  between  the  severity
of  the  condition  and  extended  MRI  abnormalities.
MRI and differential diagnosis
The  main  differential  diagnoses  for  eosinophilic  fasciitis
using  MRI  include  superﬁcial  and  deep  tissue  (dermis,  hypo-
dermis,  muscle)  conditions  such  as  the  following.
Figure 3. MRI variant of eosinophilic fasciitis in a 36-year-old
man. STIR-weighted axial sequence of the upper (a) and medium
(b) thirds of the legs showing asymmetric predominantly left-sided
involvement with moderate thickening (high signal intensity) of
the deep intermuscular fasciae (arrows) associated with inﬁltration
(high signal intensity on STIR-weighted sequence) of the anterior
portion of the left medial gastrocnemius muscle (asterisk) and hypo-
dermic tissue (arrowheads).
Cutaneous scleroderma or morphea
The  MRI  ﬁndings  of  cutaneous  scleroderma  or  morphea  are
generally  limited  to  the  skin  and  subcutaneous  fat  but  can
however  frequently  extend  to  the  deep  fasciae  and  muscles,
and  rarely  to  bone  marrow  and  joints  (Figs.  4,  5)  [25].  During
the  inﬂammatory  phase  of  these  conditions,  lesions  consist
of  a  thickening  of  the  dermis  and  a  variable  degree  of  sub-
cutaneous  tissue  inﬁltration  that  appears  as  a hypointense
signal  on  T1-weighted  sequences  and  a  hyperintense  signal
on  T2-weighted  STIR  sequences  or  T1-weighted  sequences
following  administration  of  a  gadolinium  chelate.  Fascia
thickening  is  however  limited  compared  to  that  observed
in  the  typical  form  of  eosinophilic  fasciitis  [25]. Calciﬁca-
tions  (calcinosis)  may  be  observed  in  soft  tissue,  but  are  not
disease-speciﬁc  [26].
Other  connective  tissue  diseases  may  show  abnormalities
of  deep  soft  tissues.  For  example,  systemic  lupus  erythe-
matous  and  Sjögren’s  syndrome  are  sometimes  associated
with  myositis-like  abnormal  MRI  muscle  signal  intensities
[27]. The  distribution  of  such  abnormalities  can  be  variable,
focal  or  diffuse  [27,28]  and  may  be  associated  with  bone
abnormalities  [29].
Stasis edema
Stasis  edema  is  characterized  by  an  inﬁltration  of  hypo-
dermic  tissue  that  appears  as  a  hyperintense  signal  on
T2-weighted  images,  of  generally  diffuse  and  symmet-
ric  distribution,  that  is  not  enhanced  after  injection
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Figure 4. Fasciitis of the right forearm of a 39-year-old woman with systemic sclerosis. Axial STIR and T1SE-weighted sequences. Diffuse
fascial thickening (high signal intensity on STIR-weighted sequence) (arrowheads) with adjacent muscle inﬁltration (arrows).
Figure 5. Myositis of the lower limb in a 54-year-old woman with
systemic sclerosis. Axial STIR-weighted sequences clearly reveal
edematous inﬁltrated hypodermic fat next to the gluteus maximus
(a: arrows) associated with edema-like signal abnormalities of the
muscles of the anterior compartments of the left, and to a lesser
extent right, thighs (b: asterisks).
of  gadolinium-based  contrast  agent  (‘‘cold  edema’’)  [4]
(Fig.  6).
Erysipelas
Erysipelas  is  a  common  dermo-hypodermitis  caused  by  bac-
terial  infection  that  is  clinically  diagnosed.  MRI  is  not
indicated  for  its  typical  form,  but  if  performed,  reveals
subcutaneous  inﬁltration  of  high  intensity  on  T2-weighted
images  extending  to  the  fasciae,  of  typically  asymmetric
and  more  or  less  localized  distribution,  that  is  enhanced  fol-
lowing  injection  of  gadolinium-based  contrast  agent  (‘‘hot
edema’’)  [4]  (Fig.  7).
Necrotizing fasciitis
Necrotizing  fasciitis  is  a  rare  but  potentially  lethal  infec-
tion.  MRI  assessment  is  used  to  evaluate  the  depth  of  the
lesions,  localize  abscesses  in  soft  tissues  and  guide  surgi-
cal  management.  Although  in  theory  easy,  it  is  often  more
difﬁcult  in  practice  to  differentiate  between  superﬁcial
lesions  that  can  be  managed  medically  and  deep  lesions
that  require  surgical  management  [4].  Necrotizing  fasciitis
is  characterized  by  deep  intermuscular  fasciae  involvement,
a  sensitive  but  fairly  non-speciﬁc  sign  that  can  be  associated
Figure 6. Stasis edema from the ankle of a 79-year-old woman with heart failure. Axial T1 (a) and STIR-weighted (b) sequences of the
distal third of the right leg. Diffuse ﬂuid inﬁltration of dermal (arrowheads) and hypodermal (arrows) tissue is visible (low signal intensity
on T1-weighted and high signal intensity on STIR-weighted sequences). No muscle involvement (asterisks) was observed.
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Figure 7. Bacterial dermo-hypodermitis (erysipelas) of the anteromedial aspect of the right lower leg in a 66-year-old woman. Fluid
inﬁltration of hypodermic tissue (low signal intensity on T1-weighted sequence; a: arrows). The STIR sequence provides improved visibility
(b: arrows) with enhancement (c: arrowheads) and no involvement of muscles or deep fasciae.
Figure 8. Necrotizing fasciitis in the left thigh of a 34-year-old
man with Staphylococcus aureus septicemia. a. Axial STIR-weighted
sequence showing thickening of the skin and inﬁltrated hypodermic
fat on the medial thigh (arrowheads), as well as thickening of deep
peripheral fasciae (arrow) and, to a greater extent, deep inter-
muscular fasciae (black asterisk). b. Axial T1SE-weighted sequence
after injection of gadolinium-based contrast agent highlighting
non-enhanced ﬂuid collection (white asterisk) within thickened
enhanced deep intermuscular fasciae.
with  abscesses  that  are  generally  better  visualized  follow-
ing  injection  of  gadolinium-based  contrast  agent  (Fig.  8)  [4].
Diffuse  muscular  edema  is  often  observed  [28].  An  addi-
tional  but  inconsistent  feature  is  the  presence  of  gas  (a
hypointense  signal  whatever  the  sequence)  that  is  strongly
evocative  of  necrosis.
Myositis or inﬂammatory myopathies
Myositis  or  inﬂammatory  myopathies  are  general  terms
used  to  qualify  several  conditions,  the  main  subcate-
gories  being  dermatomyositis,  polymyositis  and  inclusion
body  myositis  [30].  The  MRI  ﬁndings  for  these  myopathies
are  hyperintense  muscle  signal  on  fat-suppressed  T2-
weighted  sequences  with  contrast  enhancement.  Bilateral
Figure 9. Dermatomyositis in a 19-year-old man with symmetric
multifocal skin rash and inﬂammatory-like joint pain predominat-
ing in the upper limbs. a. Axial STIR-weighted sequence showing
symmetric involvement with high signal inﬁltrated cutaneous tis-
sues (arrowheads) and thickening (high signal intensity) of the deep
peripheral fasciae of the deltoids (arrows). b. Axial T1-weighted
sequence showing neither amyotrophia nor fatty involution of
affected muscle groups (asterisks).
and  symmetric  involvement  is  generally  observed  in  der-
matomyositis  and  polymyositis,  less  frequently  in  inclusion
body  myositis  and  the  condition  is  generally  localized  within
a  muscle  in  patients  with  focal  myositis  [27].  T1-weighted
sequences  are  used  to  evaluate  the  chronic  manifestation  of
the  disease,  i.e.  amyotrophy  and  fatty  involution  of  affected
muscle  groups.  Dermatomyositis  is  characterized  clinically
by  the  presence  of  skin  lesions  which  were,  in  the  14  cases
described  by  Yoshida  et  al.,  systematically  associated  with
fascia  involvement  (Fig.  9) [31]. In  the  population  of  25
patients  with  progressive  polymyositis  studied  by  Dion  et  al.,
muscle  signal  abnormalities  predominated  along  the  fasciae
Eosinophilic  fasciitis:  Typical  abnormalities  and  differential  diagnosis  using  MR  imaging  347
Figure 10. Polymyositis in a 33-year-old woman with muscle
pain in all four limbs. MRI of the thighs: a. Axial T1-weighted
sequence showing discrete symmetric fatty involution of the antero-
medial and posterior compartments (arrowheads). b. Axial T2
STIR-weighted sequence showing symmetric muscle inﬁltration
(high signal intensity) especially in the rectus femoris (arrows) and
adductor longus (stars) muscles. Symmetric inﬁltration (high signal
intensity) of the deep peripheral fasciae was also observed (arrow-
heads).
(usually  global  involvement)  or  the  posterior  compartments
of  the  thigh  (Fig.  10)  [32].
The  signal  abnormalities  of  deep  fasciae  observed  on
T2-weighted  MR  images  are  therefore  not  speciﬁc  and  can
be  observed  in  various  conditions  such  as  from  ruptured
popliteal  cyst  or  necrotizing  fasciitis  [33].  It  is  therefore
essential  that  imaging  results  be  combined  with  clinical,  lab-
oratory  and  if  necessary  anatomical  pathology  data  before
making  diagnosis.
Conclusion
Eosinophilic  fasciitis  is  a  rare  disease.  Diagnosis  is  guided
by  its  clinical  manifestations  and  then  further  conﬁrmed  by
anatomical  pathology  examination  of  deep  skin  biopsies.  MRI
is  the  ideal  imaging  modality  both  for  selecting  the  best  site
for  biopsy  and  monitoring  the  course  of  the  disease  follow-
ing  initiation  of  treatment.  MRI  ﬁndings  for  the  typical  form
generally  evidence  only  fasciae  involvement,  but  less  fre-
quently  MRI  signal  abnormalities  may  be  observed  in  the
muscle  and  hypodermic  tissue  adjacent  to  the  fascia.  Differ-
ential  diagnosis  of  eosinophilic  fasciitis  by  MRI  requires  the
exclusion  of  other  superﬁcial  and  deep  subcutaneous  tissue
conditions  that  produce  abnormal  signal  intensities  for  the
fascia.  It  is  therefore  crucial  that  imaging  be  combined  with
all  other  data  (clinical,  laboratory  and  anatomical  pathol-
ogy)  if  eosinophilic  fasciitis  is  suspected.
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